|
DNAJC18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.182200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.159600E-02 |
| Normal-vs-Stage2 |
5.052400E-01 |
| Normal-vs-Stage3 |
1.555360E-03 |
| Normal-vs-Stage4 |
7.773900E-04 |
| Stage1-vs-Stage2 |
4.312600E-01 |
| Stage1-vs-Stage3 |
6.725600E-02 |
| Stage1-vs-Stage4 |
2.692300E-02 |
| Stage2-vs-Stage3 |
8.205500E-02 |
| Stage2-vs-Stage4 |
3.846300E-02 |
| Stage3-vs-Stage4 |
5.324400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.599300E-03 |
| Normal-vs-AfricanAmerican |
5.814400E-01 |
| Normal-vs-Asian |
7.114600E-01 |
| Caucasian-vs-AfricanAmerican |
1.784000E-01 |
| Caucasian-vs-Asian |
2.467900E-02 |
| AfricanAmerican-vs-Asian |
7.933000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.296400E-03 |
| Normal-vs-Female |
4.582100E-02 |
| Male-vs-Female |
1.802240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.774300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.154500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.937600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.224500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.123200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.224630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.296600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.780800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.062600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.540400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.622700E-04 |
| Classical-VS-Follicular |
2.444300E-02 |
| Classical-VS-Other |
1.459630E-01 |
| Classical-VS-Normal |
1.714770E-01 |
| Tall-VS-Follicular |
2.658400E-01 |
| Tall-VS-Other |
8.168600E-01 |
| Tall-VS-Normal |
4.972400E-04 |
| Follicular-VS-Other |
5.308400E-01 |
| Follicular-VS-Normal |
7.623100E-03 |
| Other-VS-Normal |
3.832100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.103700E-02 |
| Normal-vs-N1 |
7.555300E-04 |
| N0-vs-N1 |
9.910400E-02 |
|
|
